Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q2 FY22 results · Jul–Sep 2021

Fortis Healthcare reported revenue from operations of ₹1,462.54 crore (up 47.0% from Q2 FY21) and net profit of ₹130.60 crore (up 744.2% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY22	Q2 FY21	YoY	Q1 FY22	QoQ
Revenue from operations	1,462.54	994.70	+47.0%	1,410.31	+3.7%
Other income	8.02	25.60	−68.7%	7.84	+2.3%
Total income	1,470.56	1,020.30	+44.1%	1,418.15	+3.7%
Profit before share of associates & JVs and tax	177.79	29.80	+496.6%	477.89	−62.8%
Share of profit/(loss) of associates & JVs	4.24	8.25		8.50
Net profit for the period	130.60	15.47	+744.2%	430.61	−69.7%
Attributable to shareholders of the company	106.86	(3.91)	Turned profit	263.55	−59.5%
EPS, basic (₹)	1.42	(0.05)	Turned profit	3.49	−59.3%
Net margin (%)	8.9	1.6		30.5

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q2 FY22	Q2 FY21	YoY	Q1 FY22	QoQ
Revenue from operations	220.87	153.13	+44.2%	203.52	+8.5%
Other income	33.45	54.50	−38.6%	33.49	−0.1%
Total income	254.32	207.63	+22.5%	237.01	+7.3%
Profit before tax	6.29	5.71	+10.2%	(2.34)	Turned profit
Net profit for the period	4.17	4.15	+0.5%	(1.73)	Turned profit
EPS, basic (₹)	0.05	0.06	−16.7%	(0.02)	Turned profit
Net margin (%)	1.9	2.7		-0.9

Consolidated

Filed with BSE: 12 Nov 2021, 20:39 IST
Board meeting: 12 Nov 2021
Period: 01 Jul 2021 to 30 Sep 2021
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 12 Nov 2021, 20:39 IST
Board meeting: 12 Nov 2021
Period: 01 Jul 2021 to 30 Sep 2021
Review status: Unaudited
Source: XBRL filing on BSE